BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4684295)

  • 1. Methadone--a reevaluation.
    Martin WR; Jasinski DR; Haertzen CA; Kay DC; Jones BE; Mansky PA; Carpenter RW
    Arch Gen Psychiatry; 1973 Feb; 28(2):286-95. PubMed ID: 4684295
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological sex influences sleep phenotype in mice experiencing spontaneous opioid withdrawal.
    Tisdale RK; Sun Y; Park S; Ma SC; Haire M; Allocca G; Bruchas MR; Morairty SR; Kilduff TS
    J Sleep Res; 2024 May; 33(3):e14037. PubMed ID: 37731248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing different paradigms of morphine withdrawal on sleep behavior in male and female C57BL/6J mice.
    Bedard ML; Lord JS; Perez PJ; Bravo IM; Teklezghi AT; Tarantino LM; Diering GH; McElligott ZA
    Behav Brain Res; 2023 Jun; 448():114441. PubMed ID: 37075956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing different paradigms of morphine withdrawal on sleep behavior in male and female C57BL/6J mice.
    Bedard ML; Lord JS; Perez PJ; Bravo IM; Teklezghi AT; Tarantino L; Diering G; McElligott ZA
    bioRxiv; 2023 Feb; ():. PubMed ID: 36415467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between Sleep Disturbance and Opioid Use Disorder: A Narrative Review.
    Fathi HR; Yoonessi A; Khatibi A; Rezaeitalab F; Rezaei-Ardani A
    Addict Health; 2020 Apr; 12(2):140-158. PubMed ID: 32782736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional Relationship between Opioids and Disrupted Sleep: Putative Mechanisms.
    Eacret D; Veasey SC; Blendy JA
    Mol Pharmacol; 2020 Oct; 98(4):445-453. PubMed ID: 32198209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use disorder.
    Strang J; Volkow ND; Degenhardt L; Hickman M; Johnson K; Koob GF; Marshall BDL; Tyndall M; Walsh SL
    Nat Rev Dis Primers; 2020 Jan; 6(1):3. PubMed ID: 31919349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy.
    Bertz JW; Epstein DH; Reamer D; Kowalczyk WJ; Phillips KA; Kennedy AP; Jobes ML; Ward G; Plitnick BA; Figueiro MG; Rea MS; Preston KL
    J Subst Abuse Treat; 2019 Nov; 106():43-57. PubMed ID: 31540611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.
    Koob GF; Colrain IM
    Neuropsychopharmacology; 2020 Jan; 45(1):141-165. PubMed ID: 31234199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.
    Angarita GA; Emadi N; Hodges S; Morgan PT
    Addict Sci Clin Pract; 2016 Apr; 11(1):9. PubMed ID: 27117064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence.
    Huhn AS; Harris J; Cleveland HH; Lydon DM; Stankoski D; Cleveland MJ; Deneke E; Bunce SC
    Brain Res Bull; 2016 May; 123():94-101. PubMed ID: 26876756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence.
    Huhn AS; Meyer RE; Harris JD; Ayaz H; Deneke E; Stankoski DM; Bunce SC
    Brain Res Bull; 2016 May; 123():102-9. PubMed ID: 26711857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting insomnia and battling lethargy: the yin and yang of palliative care.
    Davis MP; Goforth H
    Curr Oncol Rep; 2014 Apr; 16(4):377. PubMed ID: 24535303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological maintenance treatments of opiate addiction.
    Bell J
    Br J Clin Pharmacol; 2014 Feb; 77(2):253-63. PubMed ID: 23210630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Jage J
    Schmerz; 1989 Sep; 3(3):155-65. PubMed ID: 18415356
    [No Abstract]   [Full Text] [Related]  

  • 16. A risk-benefit analysis of methadone maintenance treatment.
    Bell J; Zador D
    Drug Saf; 2000 Mar; 22(3):179-90. PubMed ID: 10738842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic treatment with methadone and naltrexone on sleep in addicts.
    Staedt J; Wassmuth F; Stoppe G; Hajak G; Rodenbeck A; Poser W; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(6):305-9. PubMed ID: 8908412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of cocaine's abuse liability in methadone maintenance patients.
    Preston KL; Sullivan JT; Strain EC; Bigelow GE
    Psychopharmacology (Berl); 1996 Jan; 123(1):15-25. PubMed ID: 8741950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reminiscence of an addictionologist: thoughts of a researcher and clinician.
    Mansky PA
    Psychiatr Q; 1993; 64(2):81-106. PubMed ID: 8316601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.
    Azolosa JL; Stitzer ML; Greenwald MK
    Psychopharmacology (Berl); 1994 Feb; 114(1):71-80. PubMed ID: 7846209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.